GlaxoSmithKline to close Pennsylvania facility, cut 260 jobs

GlaxoSmithKline will close its facility in Carlisle, Pa., and cut 260 jobs, PennLive reported

The U.K.-based drugmaker told PennLive the decision to close the facility was made to "consolidate volumes and generate efficiencies by moving the site’s production to our Guayama, Puerto Rico facility."

The facility, which was used to make GlaxoSmithKline's product Emergen-C, a vitamin C supplement, will be closed by the end of 2021. 

Read the full article here

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars